Active, not recruitingNo phase
14022 ATTUNE Cementless RP Clinical Performance Evaluation
Key facts
- Who runs it
- DePuy Orthopaedics
- Where
- Brooklyn, Chapel Hill, DeLand, Denver, Egg Harbor, Kingsport, Lebanon, Lubbock, New London, and Newport News, United StatesSee the 10 sitesAlso in 8 other countries, 10 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 540 people, planned
- Started
- 1 Sept 2016
- Expected to end
- 1 Sept 2027
- Type of study
- Interventional
- Treatments tested
- Cementless Total Knee Arthroplasty
- Record updated
- 3 November 2026
Who can take part
- Age
- 22 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Subject is male or female and between the ages of 22 and 80 years at the time of surgery, inclusive
- Subject was diagnosed with NIDJD
- Subject, in the opinion of the Investigator, is a suitable candidate for cementless primary TKA using the devices described in this CIP with either resurfaced or non-resurfaced patellae
- Subject that is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
- Subject is currently not bedridden
- Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures
- Subject is able to read, and comprehend the Informed Consent Document as well as complete the required PROs in either English or one of the available translations
Who cannot take part
- Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee
- Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three (3) months
- Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements
- Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia
- Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing (e.g., muscular dystrophy, multiple sclerosis, Charcot disease)
- Subject has a medical condition with less than five (5) years life expectancy
- The Subject is a woman who is pregnant or lactating
- Contralateral knee has already been enrolled in this study
- Subject had a contralateral amputation
- Subject is currently diagnosed with radicular pain from the spine that radiates into the limb to receive TKA
- Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims
- Subject is suffering from inflammatory arthritis (e.g., rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.)
- Uncontrolled gout
Where in United States
Also in 8 other countries, 10 sites
- SUNY Downstate Medical CenterBrooklyn, United StatesNo longer taking part
- UNC- Chapel HillChapel Hill, United StatesNo longer taking part
- Florida Research AssociatesDeLand, United StatesNo longer taking part
- Colorado Joint ReplacementDenver, United StatesNo longer taking part
- Rothman InstituteEgg Harbor, United StatesNo longer taking part
- Associated Orthopaedics of KingsportKingsport, United StatesNo longer taking part
- Dartmouth Hitchcock Medical CenterLebanon, United StatesNo longer taking part
- Texas Tech University Heath Science CenterLubbock, United StatesNo longer taking part
- New London HospitalNew London, United StatesNo longer taking part
- Hampton Roads Orthopaedics and Sports MedicineNewport News, United StatesNo longer taking part
About the trial
What the trial wants to find out
The primary objective of this study is to examine the change from pre-operative baseline to two year postoperative functional performance improvement for the ATTUNE primary, cementless TKA RP system as measured with the KOOS questionnaire (KOOS-ADL sub-score). This will be carried out for two configurations: cruciate retaining rotating platform (ATTUNE Cementless CR RP) and posterior stabilized rotating platform (ATTUNE Cementless PS RP).
The group in the trial
- ATTUNE Cementless RP TKATreatment being tested
Subjects will receive a cementless, rotating platform total knee arthroplasty
Treatment: Cementless Total Knee Arthroplasty
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Multi-Center Clinical Evaluation of the ATTUNE Cementless Rotating Platform Total Knee Arthroplasty
- Record updated
- 3 November 2026